search
Back to results

2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients (DeSSI)

Primary Purpose

Surgical Site Infections, Post Operative Complication

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
2% chlorhexidine gluconate cloths
Sponsored by
Vanderbilt University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Surgical Site Infections focused on measuring skin flora

Eligibility Criteria

19 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Patients scheduled for a neuro-spine procedure and have 2 of the following risk factors:

  • Diabetic OR
  • BMI>30 OR
  • ASA>2 OR
  • pre-operatively hospitalized OR
  • >60 years old OR
  • chronic steroids/immunosuppressive medications OR
  • prior history of SSI

Exclusion Criteria:

  • Unable to consent
  • Non English speaking
  • Known allergy to any of the ingredients contained in SAGE chlorhexidine gluconate cloths
  • Current infection or history of spine infections
  • Patients with tumors or intradural spinal pathology.

Sites / Locations

  • Vanderbilt University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control Arm

Intervention Arm

Arm Description

Standard of care pre-operative cleansing with soap and water the night before and morning of surgery

2% chlorhexidine gluconate cloths the night before and morning of surgery

Outcomes

Primary Outcome Measures

Participants With Surgical Site Infection Development at 30 Days Post-operative
Evaluation daily using the CDC guidelines, daily measurements and deidentified photos

Secondary Outcome Measures

Number of Participants With Positive or Abnormal Skin Cultures on Day of Surgery, Day of Discharge, 30 Days Post-op
Skin swabs collected on Day of Surgery, Day of Discharge, 30 days post-op

Full Information

First Posted
June 16, 2015
Last Updated
December 14, 2020
Sponsor
Vanderbilt University
Collaborators
Sage Products, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT02490631
Brief Title
2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients
Acronym
DeSSI
Official Title
A Randomized Controlled Trial of 2% Chlorhexidine Gluconate Skin Preparation Cloths for the Prevention of Post op Surgical Site Infections in Spine Patients (Decrease SSI or DeSSI)
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
August 2015 (Actual)
Primary Completion Date
December 30, 2018 (Actual)
Study Completion Date
December 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vanderbilt University
Collaborators
Sage Products, Inc.

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Surgical site infection (SSI) following spinal surgery is a frequent complication and results in higher morbidity, mortality and healthcare costs. SSI following adult spinal surgery is a frequent complication that has been reported to occur in 0.7-12.0% of patients and result in higher postoperative morbidity, mortality and health care costs. Vanderbilt University Medical Center SSI rate is 7%. Treatment for SSI can be challenging often requiring revision surgery, long-term antibiotics, and prolonged hospitalization. The accurate identification of risk factors is thus important in the development of strategies to prevent these potentially devastating infections. This study proposes a randomized, controlled trial of neuro-spine patients of 2% chlorhexidine gluconate skin preparation cloths for the prevention of post op surgical site infections in spine patients. Use of CHG cloths the night before and morning of surgery (neckline to toes) will affect (decrease rates) of SSI compared to patients who receive routine standard of care (soap and water pre-op, day of surgery and daily post-operative).
Detailed Description
Pre-operatively patients scheduled for neurosurgical spine cases will be evaluated and approached for interest, if consenting process completed, patients will be randomized to one of 2 arms in 1:1 through a block randomization table. Those enrolled into the study arm will receive the CHG cloths and instructions for use from research personal. Those randomized to the control arm will receive standard of care skin cleansing by nursing staff. All subjects who have signed consent will have a skin swab culture taken the day of screening and prior to cleansing with Chlorhexidine gluconate wipes close to the intended incision line. The investigators will also obtain skin swab cultures at site of incision preoperatively on the day of surgery, post-op day 4 or time of discharge and at the 30 day follow up. Both groups will be evaluated daily by study personnel for the development of SSI until post-op day 4 or hospital discharge whichever one comes first. After dressing removal, a daily high definition picture will be taken of the incision line to further document signs of SSI development (pictures will not have any patient identifiable information). Additional evaluations will take place at the 30 day (+/- 7 days) post-op visit. Blinded evaluators utilizing the CDC guideline will grade the incision line for presence of SSI. Measured change in skin flora will be performed by comparing skin swab cultures of intervention group versus standard of care group and individual changes pre and post operatively.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Surgical Site Infections, Post Operative Complication
Keywords
skin flora

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
158 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control Arm
Arm Type
No Intervention
Arm Description
Standard of care pre-operative cleansing with soap and water the night before and morning of surgery
Arm Title
Intervention Arm
Arm Type
Experimental
Arm Description
2% chlorhexidine gluconate cloths the night before and morning of surgery
Intervention Type
Drug
Intervention Name(s)
2% chlorhexidine gluconate cloths
Other Intervention Name(s)
SAGE patient preoperative skin preparation cloths
Intervention Description
Cleansing twice pre-operatively jawline to toes with 2% chlorhexidine gluconate cloths
Primary Outcome Measure Information:
Title
Participants With Surgical Site Infection Development at 30 Days Post-operative
Description
Evaluation daily using the CDC guidelines, daily measurements and deidentified photos
Time Frame
post op day 30
Secondary Outcome Measure Information:
Title
Number of Participants With Positive or Abnormal Skin Cultures on Day of Surgery, Day of Discharge, 30 Days Post-op
Description
Skin swabs collected on Day of Surgery, Day of Discharge, 30 days post-op
Time Frame
Day of Surgery, Day of Discharge, 30 days post-op

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients scheduled for a neuro-spine procedure and have 2 of the following risk factors: Diabetic OR BMI>30 OR ASA>2 OR pre-operatively hospitalized OR >60 years old OR chronic steroids/immunosuppressive medications OR prior history of SSI Exclusion Criteria: Unable to consent Non English speaking Known allergy to any of the ingredients contained in SAGE chlorhexidine gluconate cloths Current infection or history of spine infections Patients with tumors or intradural spinal pathology.
Facility Information:
Facility Name
Vanderbilt University Medical Center
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37232
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
8547767
Citation
Abbey DM, Turner DM, Warson JS, Wirt TC, Scalley RD. Treatment of postoperative wound infections following spinal fusion with instrumentation. J Spinal Disord. 1995 Aug;8(4):278-83. doi: 10.1097/00002517-199508040-00003.
Results Reference
background
Citation
Balderston RA, Blumberg K (1991) Infection in spine surgery. In: Balderston RA, An HS (eds) Complications in spinal surgery. WB Saunders, Philadelphia, pp 157-168
Results Reference
background
PubMed Identifier
8893444
Citation
Glassman SD, Dimar JR, Puno RM, Johnson JR. Salvage of instrumental lumbar fusions complicated by surgical wound infection. Spine (Phila Pa 1976). 1996 Sep 15;21(18):2163-9. doi: 10.1097/00007632-199609150-00021.
Results Reference
background
PubMed Identifier
5012590
Citation
Keller RB, Pappas AM. Infection after spinal fusion using internal fixation instrumentation. Orthop Clin North Am. 1972 Mar;3(1):99-111. No abstract available.
Results Reference
background
PubMed Identifier
4722945
Citation
Kostuik JP, Israel J, Hall JE. Scoliosis surgery in adults. Clin Orthop Relat Res. 1973 Jun;(93):225-34. doi: 10.1097/00003086-197306000-00022. No abstract available.
Results Reference
background
PubMed Identifier
4584242
Citation
Lonstein J, Winter R, Moe J, Gaines D. Wound infection with Harrington instrumentation and spine fusion for scoliosis. Clin Orthop Relat Res. 1973 Oct;(96):222-33. No abstract available.
Results Reference
background
PubMed Identifier
9507627
Citation
Roberts FJ, Walsh A, Wing P, Dvorak M, Schweigel J. The influence of surveillance methods on surgical wound infection rates in a tertiary care spinal surgery service. Spine (Phila Pa 1976). 1998 Feb 1;23(3):366-70. doi: 10.1097/00007632-199802010-00016.
Results Reference
background
PubMed Identifier
2053001
Citation
West JL 3rd, Ogilvie JW, Bradford DS. Complications of the variable screw plate pedicle screw fixation. Spine (Phila Pa 1976). 1991 May;16(5):576-9. doi: 10.1097/00007632-199105000-00016.
Results Reference
background
PubMed Identifier
12650399
Citation
Olsen MA, Mayfield J, Lauryssen C, Polish LB, Jones M, Vest J, Fraser VJ. Risk factors for surgical site infection in spinal surgery. J Neurosurg. 2003 Mar;98(2 Suppl):149-55.
Results Reference
background
PubMed Identifier
8539047
Citation
Calderone RR, Garland DE, Capen DA, Oster H. Cost of medical care for postoperative spinal infections. Orthop Clin North Am. 1996 Jan;27(1):171-82.
Results Reference
background
PubMed Identifier
8059266
Citation
Davis H. Increasing rates of cervical and lumbar spine surgery in the United States, 1979-1990. Spine (Phila Pa 1976). 1994 May 15;19(10):1117-23; discussion 1123-4. doi: 10.1097/00007632-199405001-00003.
Results Reference
background
PubMed Identifier
17436915
Citation
Patel N, Bagan B, Vadera S, Maltenfort MG, Deutsch H, Vaccaro AR, Harrop J, Sharan A, Ratliff JK. Obesity and spine surgery: relation to perioperative complications. J Neurosurg Spine. 2007 Apr;6(4):291-7. doi: 10.3171/spi.2007.6.4.1.
Results Reference
background
PubMed Identifier
18303461
Citation
Rihn JA, Lee JY, Ward WT. Infection after the surgical treatment of adolescent idiopathic scoliosis: evaluation of the diagnosis, treatment, and impact on clinical outcomes. Spine (Phila Pa 1976). 2008 Feb 1;33(3):289-94. doi: 10.1097/BRS.0b013e318162016e.
Results Reference
background
PubMed Identifier
20066445
Citation
Pull ter Gunne AF, van Laarhoven CJ, Cohen DB. Incidence of surgical site infection following adult spinal deformity surgery: an analysis of patient risk. Eur Spine J. 2010 Jun;19(6):982-8. doi: 10.1007/s00586-009-1269-1. Epub 2010 Jan 12.
Results Reference
background
PubMed Identifier
19478664
Citation
Pull ter Gunne AF, Cohen DB. Incidence, prevalence, and analysis of risk factors for surgical site infection following adult spinal surgery. Spine (Phila Pa 1976). 2009 Jun 1;34(13):1422-8. doi: 10.1097/BRS.0b013e3181a03013.
Results Reference
background
PubMed Identifier
19494763
Citation
Eiselt D. Presurgical skin preparation with a novel 2% chlorhexidine gluconate cloth reduces rates of surgical site infection in orthopaedic surgical patients. Orthop Nurs. 2009 May-Jun;28(3):141-5. doi: 10.1097/NOR.0b013e3181a469db.
Results Reference
background
PubMed Identifier
22889522
Citation
Karki S, Cheng AC. Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. J Hosp Infect. 2012 Oct;82(2):71-84. doi: 10.1016/j.jhin.2012.07.005. Epub 2012 Aug 11.
Results Reference
background
PubMed Identifier
23388005
Citation
Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, Weinstein RA, Sepkowitz KA, Jernigan JA, Sanogo K, Wong ES. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med. 2013 Feb 7;368(6):533-42. doi: 10.1056/NEJMoa1113849. Erratum In: N Engl J Med. 2013 Jun 13;368(24):2341.
Results Reference
background
PubMed Identifier
23363666
Citation
Milstone AM, Elward A, Song X, Zerr DM, Orscheln R, Speck K, Obeng D, Reich NG, Coffin SE, Perl TM; Pediatric SCRUB Trial Study Group. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet. 2013 Mar 30;381(9872):1099-106. doi: 10.1016/S0140-6736(12)61687-0. Epub 2013 Jan 28.
Results Reference
background

Learn more about this trial

2% Chlorhexidine Gluconate Skin Cloths to Prevent SSI in Spine Surgery Patients

We'll reach out to this number within 24 hrs